Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex.

Nature | 2009

Brown adipose cells are specialized to dissipate chemical energy in the form of heat, as a physiological defence against cold and obesity. PRDM16 (PR domain containing 16) is a 140 kDa zinc finger protein that robustly induces brown fat determination and differentiation. Recent data suggests that brown fat cells arise in vivo from a Myf5-positive, myoblastic lineage by the action of PRDM16 (ref. 3); however, the molecular mechanisms responsible for this developmental switch is unclear. Here we show that PRDM16 forms a transcriptional complex with the active form of C/EBP-beta (also known as LAP), acting as a critical molecular unit that controls the cell fate switch from myoblastic precursors to brown fat cells. Forced expression of PRDM16 and C/EBP-beta is sufficient to induce a fully functional brown fat program in naive fibroblastic cells, including skin fibroblasts from mouse and man. Transplantation of fibroblasts expressing these two factors into mice gives rise to an ectopic fat pad with the morphological and biochemical characteristics of brown fat. Like endogenous brown fat, this synthetic brown fat tissue acts as a sink for glucose uptake, as determined by positron emission tomography with fluorodeoxyglucose. These data indicate that the PRDM16-C/EBP-beta complex initiates brown fat formation from myoblastic precursors, and may provide opportunities for the development of new therapeutics for obesity and type-2 diabetes.

Pubmed ID: 19641492 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCRR NIH HHS, United States
    Id: S10-RR-023010
  • Agency: NIDDK NIH HHS, United States
    Id: K99 DK087853
  • Agency: NIDDK NIH HHS, United States
    Id: R00 DK081605
  • Agency: NIDDK NIH HHS, United States
    Id: R37 DK031405
  • Agency: NIDDK NIH HHS, United States
    Id: DK081605
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM067945
  • Agency: NHGRI NIH HHS, United States
    Id: R01 HG003456
  • Agency: NIGMS NIH HHS, United States
    Id: GM67945
  • Agency: NIDDK NIH HHS, United States
    Id: R37 DK031405-28
  • Agency: NHGRI NIH HHS, United States
    Id: HG3456
  • Agency: NIDDK NIH HHS, United States
    Id: DK31405
  • Agency: NIDDK NIH HHS, United States
    Id: K99 DK081605
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK031405
  • Agency: NCRR NIH HHS, United States
    Id: S10 RR023010

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Harvard University; Cambridge; United States (tool)

RRID:SCR_011273

Institution of higher education in the United States. Private Ivy League research university in Cambridge, Massachusetts.

View all literature mentions

C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions